A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants
NCT05667779
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
QRL-101
OTHER:
Placebo
Sponsor
QurAlis Corporation